Joint Formulary Newsletter
Bedfordshire and Luton Joint Formulary Newsletter
October 2019, Number 1
Incorporates Key Recommendations from The Bedfordshire and Luton Joint Prescribing Committee (JPC) 18th September 2019
The Bedfordshire and Luton Joint Formulary (a combined medicines formulary for use by BCCG, LCCG, Bedford Hospital and the Luton and Dunstable University Hospital) is now ‘live’. It can be accessed here
Unless otherwise stated decisions made apply to all organisations in the Joint Formulary Group.
|FORMULARY TRAFFIC LIGHT STATUS INFORMATION|
|RED||RED - Hospital Only - to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment|
|AMBER||Amber medicines are considered suitable for GP prescribing following specialist initiation|
|GREEN||These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations|
|SCG||Shared Care - These medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place, status reverts to RED.|
|BLACK||A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. DO NOT PRESCRIBE|
|The following ADDITIONS to the Joint Formulary were agreed at the JPC Committee Meeting|
In addition to the NICE Guidance (with JPC action) and inhalers outlined in the JPC October 2019 newsletter, the following additions to the Formulary were noted or ratified by the JPC:
|Hospital Drug and Therapeutic Committee Updates|
|CCG Prescribing Committees|
BCCG Prescribing Committee
LCCG Prescribing Committee
|Wound Care Formulary Group (Ratified by the JPC)|
No update from the Wound Care Group
|Decisions Made By Joint Formulary Group (Ratified by the JPC)|
Safety Needles to be made available by GP prescription only for patients who cannot self-inject and require a carer (not a healthcare professional) to administer the insulin.
Bath and shower preparations for dry and pruritic skin conditions – all products to be removed. “Leave-on” emollients to be used instead in line with national guidance.
Insulin pen needles that cost > £5 per 100 needles (all <£5 per 100 needles to be made available). Insulin pen needles of 8mm and 12 mm.
NICE Technology Appraisal Guidance – new drugs